{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:41:48Z","timestamp":1788306108001,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.vaccine.2015.04.014","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T16:21:47Z","timestamp":1428769307000},"page":"3422-3428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine"],"prefix":"10.1016","volume":"33","author":[{"given":"Mary Ann","family":"Goss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Lievano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn M.","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Seminack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2015.04.014_bib0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"issue":"11","key":"10.1016\/j.vaccine.2015.04.014_bib0150","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.vaccine.2015.04.014_bib0155","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/01.pas.0000213291.96401.48","article-title":"The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN)","volume":"30","author":"Srodon","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"16","key":"10.1016\/j.vaccine.2015.04.014_bib0160","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1016\/j.ejca.2013.06.033","article-title":"Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva","volume":"49","author":"de Sanjose","year":"2013","journal-title":"Eur J Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2015.04.014_bib0165","first-page":"S40","article-title":"A3. Vaginal intraepithelial neoplasia (VAIN)","volume":"94","author":"Hatch","year":"2006","journal-title":"Int J Gynecol Obstet"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2015.04.014_bib0170","first-page":"S42","article-title":"Anal squamous intraepithelial lesions: relation to HIV and human papillomavirus infection","volume":"21","author":"Palefsky","year":"1999","journal-title":"JAIDS"},{"key":"10.1016\/j.vaccine.2015.04.014_bib0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<65::AID-JMV10>3.0.CO;2-Z","article-title":"Human papillomavirus (HPV) DNA in penile carcinomas in Argentina: analysis of primary tumors and lymph nodes","volume":"61","author":"Picconi","year":"2000","journal-title":"J Med Virol"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2015.04.014_bib0180","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jadohealth.2010.01.016","article-title":"Beyond cervical cancer: burden of other HPV-related cancers among men and women","volume":"46","author":"Chaturvedi","year":"2010","journal-title":"J Adolesc Health"},{"issue":"10","key":"10.1016\/j.vaccine.2015.04.014_bib0185","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/522863","article-title":"The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries","volume":"196","author":"Kjaer","year":"2007","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2015.04.014_bib0190","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2015.04.014_bib0195","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/AOG.0b013e3181c2a122","article-title":"Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6\/11\/16\/18 vaccine","volume":"114","author":"Dana","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.vaccine.2015.04.014_bib0200","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/pds.868","article-title":"A five-year evaluation of reports of overdose with indinavir sulfate","volume":"12","author":"Lehman","year":"2003","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2015.04.014_bib0205","series-title":"Metropolitan Atlanta Congenital Defects Program. Surveillance procedure manual and guide to computerized anomaly record","author":"Centers for Disease Control and Prevention","year":"1998"},{"key":"10.1016\/j.vaccine.2015.04.014_bib0210","article-title":"Birth defects and genetic diseases branch 6-digit code for reportable congenital anomalies, Atlanta, GA, version 08\/07","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR: Morb Mortal Wkl Rep"},{"key":"10.1016\/j.vaccine.2015.04.014_bib0215","unstructured":"March of Dimes. Available at http:\/\/www.marchofdimes.org\/Peristats\/calculations.aspx?reg=&top=&id=24 [accessed 31.03.15]."},{"issue":"2","key":"10.1016\/j.vaccine.2015.04.014_bib0220","first-page":"65","article-title":"Reporting birth defects surveillance data, 1968\u20132003","volume":"79","author":"Correa","year":"2007","journal-title":"Birth Defects Res Part A Clin Mol Teratol"},{"issue":"8","key":"10.1016\/j.vaccine.2015.04.014_bib0225","first-page":"1","article-title":"Fetal and perinatal mortality, United States, 2005","volume":"57","author":"MacDorman","year":"2009","journal-title":"Natl Vital Stat Rep"},{"issue":"23","key":"10.1016\/j.vaccine.2015.04.014_bib0230","first-page":"1","article-title":"Estimated pregnancy rates for the United States, 1990\u20132000: an update","volume":"52","author":"Ventura","year":"2004","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.vaccine.2015.04.014_bib0235","series-title":"Foundations of epidemiology","author":"Lilienfeld","year":"1994"},{"key":"10.1016\/j.vaccine.2015.04.014_bib0240","series-title":"The pregnancy registry for GARDASIL","author":"Merck & Co., Inc.","year":"2012"},{"issue":"5 Pt 1","key":"10.1016\/j.vaccine.2015.04.014_bib0245","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/0002-9378(89)90186-5","article-title":"Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester","volume":"160","author":"Koren","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.vaccine.2015.04.014_bib0250","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/j.1552-4604.2000.tb05982.x","article-title":"Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionals","volume":"40","author":"Pole","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.vaccine.2015.04.014_bib0255","series-title":"The 2002 FDA guidance for industry: establishing pregnancy exposure registries","year":"2009"},{"key":"10.1016\/j.vaccine.2015.04.014_bib0260","series-title":"Danforth's obstetrics and gynecology","first-page":"143","article-title":"Early pregnancy loss","author":"Scott","year":"1999"},{"issue":"1","key":"10.1016\/j.vaccine.2015.04.014_bib0265","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1471-0528.1997.tb10639.x","article-title":"The management of late fetal death: a guide to comprehensive care","volume":"104","author":"Fox","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.vaccine.2015.04.014_bib0270","article-title":"Temporal trends in maternal medical conditions and stillbirth","author":"Patel","year":"2014","journal-title":"AJOG"},{"issue":"10 December (12)","key":"10.1016\/j.vaccine.2015.04.014_bib0275","doi-asserted-by":"crossref","first-page":"e114843","DOI":"10.1371\/journal.pone.0114843","article-title":"Risk assessment of adverse birth outcomes in relation to maternal age","volume":"9","author":"Weng","year":"2014","journal-title":"PLOS ONE"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2015.04.014_bib0280","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2105\/AJPH.85.5.710","article-title":"Young maternal age and congenital malformations: a population-based study","volume":"85","author":"Croen","year":"1995","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2015.04.014_bib0290","doi-asserted-by":"crossref","unstructured":"Jerrold S. Levine, M.D., D. Ware Brance, M>D>, and Joyce Rauch, Ph.D. The Antiphospholipid Syndrome. NEJM: Volume 346: 752-63, March 7, 2002, Number 10.","DOI":"10.1056\/NEJMra002974"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15004673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15004673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:23:09Z","timestamp":1759400589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15004673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":29,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0264410X15004673"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.014","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}